How did the 1-for-30 reverse stock split affect the Modular Medical (MODD) share amounts reported?

The filing explains that all reported share amounts, including the 110-share grant and 916-share total holdings, reflect a 1-for-30 reverse stock split. This reverse split of Modular Medical’s common stock was effected on March 31, 2026, consolidating prior share counts.

Modular Medical director receives 110-share stock grant

Modular Medical, Inc. director Carmen B. Volkart received a grant of common stock as part of board compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Modular Medical, Inc. director Carmen B. Volkart received a grant of common stock as part of board compensation. On the reported date, Volkart acquired 110 shares of common stock at a price of $0.00 per share, increasing direct holdings to 916 shares. The shares were issued under the company’s Outside Director Compensation Plan, and the reported share amounts reflect the impact of a 1-for-30 reverse stock split of the common stock that was effected on March 31, 2026.

Insider Trade Summary

Grant/Award: 110 shares

Grant/Award 1 txn

Insider Volkart Carmen B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	110	$0.00	$0.00

Holdings After Transaction: Common Stock — 916 shares (Direct)

Footnotes (2)

F1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
F2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Key Figures

Shares granted: 110 shares Post-transaction holdings: 916 shares Grant price: $0.00 per share +1 more

4 metrics

Shares granted 110 shares Common stock grant to director Carmen B. Volkart

Post-transaction holdings 916 shares Total direct common stock holdings after grant

Grant price $0.00 per share Stated price for compensation-related stock award

Reverse stock split ratio 1-for-30 Common stock reverse split effective March 31, 2026

Key Terms

Outside Director Compensation Plan, 1-for-30 reverse stock split, Grant, award, or other acquisition

3 terms

Outside Director Compensation Plan financial

"These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan."

1-for-30 reverse stock split financial

"Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Modular Medical (MODD) report for Carmen B. Volkart?

Modular Medical reported that director Carmen B. Volkart received a grant of 110 shares of common stock. The shares were issued under the company’s Outside Director Compensation Plan as compensation for board service rather than through an open-market purchase or sale.

How many Modular Medical (MODD) shares does Carmen B. Volkart hold after this grant?

After the reported grant, Carmen B. Volkart directly holds 916 shares of Modular Medical common stock. This total incorporates the newly granted 110 shares and reflects adjustments from a prior 1-for-30 reverse stock split of the company’s common stock.

At what price were the Modular Medical (MODD) shares granted to Carmen B. Volkart?

The 110 shares of Modular Medical common stock granted to Carmen B. Volkart carried a stated price of $0.00 per share. This indicates a compensation-related stock award rather than a cash purchase in the open market by the reporting person.

Was Carmen B. Volkart’s Modular Medical (MODD) stock grant linked to a compensation plan?

Yes. The filing states that the shares were issued to Carmen B. Volkart under Modular Medical’s Outside Director Compensation Plan. This means the transaction represents standard equity compensation for outside directors, instead of discretionary trading activity in the company’s stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/02/2026 - 04:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Volkart Carmen B

(Last)

(First)

(Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO

CALIFORNIA

92127

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		A		110	A	⁽¹⁾	916⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

	/s/ James Sullivan, Attorney in Fact for Carmen Volkart	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR